Prasinezumab (Anti-Alpha-synuclein)

Prasinezumab (Anti-Alpha-synuclein) is a humanized IgG1 monoclonal antibody targeting aggregated α-synuclein.It has the potential for Parkinson's disease research. MW :150 KD.
Supplier Selleck Chemicals
Product # A2623
Sku # A2623-1mg*5
Pricing 1mg*5, $1690.00
Feedback